Sign inJoin waitlistJoin the waitlist

Joshua Schiffer

Symposium Co-Chair · University of Washington School of Medicine

Credentials: · · · · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Infectious Disease
University of Washington-Seattle Campus
2007–2010
Johns Hopkins University School of Medicine
2002–2005
Epidemiology, University of Washington
Johns Hopkins School of Medicine
1998–2002
Undergraduate, Middlebury College
1990–1994

Research

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
New England Journal of Medicine · 2022 · 998 citations
Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis
Systematic review or meta-analysis · The Lancet Infectious Diseases · 2017 · 226 citations
Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation
Blood · 2021 · 156 citations

Keith Jerome
31 papers
Lawrence Corey
28 papers
Anna Wald
27 papers
ED
Elizabeth Duke
17 papers · 1 as a fellow
Michael Boeckh
16 papers
Christine Johnston
12 papers
Alex Greninger
9 papers · 5 as a resident
Corey Casper
9 papers
SG
Soren Gantt
9 papers
Alpana Waghmare
8 papers
Steven Deeks
7 papers
Hans-Peter Kiem
6 papers

Grants

Early Intervention with Anti-Proliferative Therapy Close to ART Initiation to Limit Long-Term SIV Persistence
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.3M · Fred Hutchinson Cancer Center
2024–2029
Development of an Oral Pan-Coronavirus Drug Cocktail
National Institute of Allergy and Infectious Diseases · R01
PI · $2.7M · University of Washington
2023–2028
Mathematical Modeling of Optimal Therapeutic Combinations for HIV Cure
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $931.8K · Fred Hutchinson Cancer Center
2019–2025
Characterizing Determinants of Primary KSHV Infection Among Children and Adolescents in Uganda
National Cancer Institute · R01
PI · $2.9M · Fred Hutchinson Cancer Center
2019–2025

Clinical trials

MMF for HIV Reservoir Reduction
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2018–2019